Clear Street’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$22.3M Sell
18,606
-95
-0.5% -$97.1K 0.06% 95
2026
Q1
$17.2M Buy
18,701
+7,282
+64% +$7.38M 0.07% 80
2025
Q4
$12.3M Sell
11,419
-28,531
-71% -$27.3M 0.05% 83
2025
Q3
$30.5M Buy
39,950
+13,000
+48% +$9.67M 0.1% 69
2025
Q2
$21M Buy
+26,950
New +$20.9M 0.08% 51

Other funds holding LLY

Clear Street's LLY Position: Q2 2026 in Review

Clear Street reduced its Eli Lilly (LLY) stake by 0.51% in Q2 2026, selling an estimated $97.1K and leaving 18,606 shares worth $22.3M. The position accounts for 0.06% of the portfolio, ranked #95.

Clear Street first reported a position in LLY in Q2 2025 and has held it in 5 quarters since. The position peaked at $30.5M in Q3 2025. 4,600 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Clear Street held 18,606 shares of Eli Lilly worth $22.3M as of Q2 2026.
  • Clear Street sold 95 Eli Lilly shares in Q2 2026, an estimated $97.1K.
  • Eli Lilly made up 0.06% of Clear Street's portfolio in Q2 2026, its #95 holding.
  • Clear Street first reported a position in Eli Lilly in Q2 2025 and has held it in 5 quarters since.
  • Clear Street's Eli Lilly position peaked at $30.5M in Q3 2025.
  • 4,600 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Clear Street's 13F filing for Q2 2026, filed 12 Aug 2026.